posted on 2018-10-02, 00:00authored byKaran Arora, Mackenzie Herroon, Malik H. Al-Afyouni, Nicholas P. Toupin, Thomas N. Rohrabaugh, Lauren M. Loftus, Izabela Podgorski, Claudia Turro, Jeremy J. Kodanko
Dual
action agents containing a cysteine protease inhibitor and
Ru-based photosensitizer for photodynamic therapy (PDT) were designed,
synthesized, and validated in 2D culture and 3D functional imaging
assays of triple-negative human breast cancer (TNBC). These combination
agents deliver and release Ru-based PDT agents to tumor cells and
cause cancer cell death upon irradiation with visible light, while
at the same time inactivating cathespin B (CTSB), a cysteine protease
strongly associated with invasive and metastatic behavior. In total
five Ru-based complexes were synthesized with the formula [Ru(bpy)<sub>2</sub>(<b>1</b>)](O<sub>2</sub>CCF<sub>3</sub>)<sub>2</sub> (<b>3</b>), where bpy = 2,2′-bipyridine and <b>1</b> = a bipyridine-based epoxysuccinyl inhibitor; [Ru(tpy)(NN)(<b>2</b>)](PF<sub>6</sub>)<sub>2</sub>, where tpy = terpiridine, <b>2</b> = a pyridine-based epoxysuccinyl inhibitor and NN = 2,2′-bipyridine
(<b>4</b>); 6,6′-dimethyl-2,2′-bipyridine (<b>5</b>); benzo[<i>i</i>]dipyrido[3,2-<i>a</i>:2′,3′-<i>c</i>]phenazine (<b>6</b>); and 3,6-dimethylbenzo[<i>i</i>]dipyrido[3,2-<i>a</i>:2′,3′-<i>c</i>]phenazine (<b>7</b>). Compound <b>3</b> contains a [Ru(bpy)<sub>3</sub>]<sup>2+</sup> fluorophore and was designed to track the subcellular
localization of the conjugates, whereas compounds <b>4</b>–<b>7</b> were designed to undergo either photoactivated ligand dissociation
and/or singlet oxygen generation. Photochemical studies confirmed
that complexes <b>5</b> and <b>7</b> undergo photoactivated
ligand dissociation, whereas <b>6</b> and <b>7</b> generate
singlet oxygen. Inhibitors <b>1</b>–<b>7</b> all
potently and irreversibly inhibit CTSB. Compounds <b>4</b>–<b>7</b> were evaluated against MDA-MB-231 TNBC and MCF-10A breast
epithelial cells in 2D and 3D culture for effects on proteolysis and
cell viability under dark and light conditions. Collectively, these
data reveal that <b>4</b>–<b>7</b> potently inhibit
dye-quenched (DQ) collagen degradation, whereas only compound <b>7</b> causes efficient cell death under light conditions, consistent
with its ability to release a Ru(II)-based photosensitizer and to
also generate <sup>1</sup>O<sub>2</sub>.